Literature DB >> 19542703

UK Renal Registry 11th Annual Report (December 2008): Chapter 15 The UK Renal Registry, UKRR database, validation and methodology.

David Ansell1, Charles R V Tomson.   

Abstract

The UK Renal Registry receives encrypted data extracts quarterly from each centre providing Renal Replacement Therapy (RRT) in England, Wales and Northern Ireland. Summary data is received from the Scottish Renal Registry to allow national statistics to be compiled. Data from patients receiving haemodialysis in satellite units or at home are reported through the main renal centre. Data from patients with functioning kidney transplants are reported through the centre providing routine clinical follow-up. The data are extracted from a variety of IT systems with varying functionality and no common messaging system, necessitating extensive data validation and cleaning prior to analysis. Growing confidence in the analyses since the inception of the Registry in 1995 has allowed de-anonymised centre-specific analyses of all outcomes, including survival, to be published, although incomplete data returns for primary renal diagnosis and comorbidity at start of RRT limit ability to adjust for case-mix. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19542703     DOI: 10.1159/000210004

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  3 in total

1.  A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy.

Authors:  Hugh Gallagher; Shona Methven; Anna Casula; Nicola Thomas; Charles R V Tomson; Fergus J Caskey; Tracey Rose; Stephen J Walters; David Kennedy; Anne Dawnay; Martin Cassidy; Richard Fluck; Hugh C Rayner; Michael Nation
Journal:  BMC Nephrol       Date:  2017-04-11       Impact factor: 2.388

2.  Magnitude of discordance between registry data and death certificate when evaluating leading causes of death in dialysis patients.

Authors:  Jean-Philippe Lafrance; Elham Rahme; Sameena Iqbal; Martine Leblanc; Vincent Pichette; Naoual Elftouh; Michel Vallée
Journal:  BMC Med Res Methodol       Date:  2013-03-27       Impact factor: 4.615

3.  Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.

Authors:  Kate Birnie; Fergus Caskey; Yoav Ben-Shlomo; Jonathan A C Sterne; Julie Gilg; Dorothea Nitsch; Charles Tomson
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.